Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Top 5 Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing

In this article, we will list the Top 5 Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing. Please visit Top 10 Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing if you would like to see the extended list and the methodology behind it.

5. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 98

Merck & Co., Inc. (NYSE:MRK) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. Merck & Co., Inc. (NYSE:MRK) announced on May 29 that calderasib (MK-1084), in combination with KEYTRUDA®, which is the company’s anti-PD-1 therapy, has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the first-line treatment of patients with advanced or metastatic non-small cell lung cancer with KRAS G12C-mutation and expressing PD-L1. Calderasib is an investigational oral specific KRAS G12C inhibitor, and this marks the first Breakthrough Therapy designation for calderasib, supported by positive data from the Phase 1 KANDLELIT-001 trial.

Dr. Shweta Jain, vice president, global clinical development, Merck Research Laboratories, stated that the Breakthrough Therapy designation for calderasib highlights the “promising potential of this medicine and unmet need for certain patients with KRAS G12C-mutated NSCLC.” Merck & Co., Inc. (NYSE:MRK) clarified that the FDA’s Breakthrough Therapy designation is granted to accelerate the development and review of medicines intended for the treatment of serious or life-threatening conditions.

Merck & Co., Inc. (NYSE:MRK) is a biopharmaceutical company that delivers health solutions to advance the treatment and prevention of diseases in animals and people. Its Pharmaceutical segment offers vaccines and human health pharmaceutical products, typically therapeutic and preventive agents. Its Animal Health segment develops, discovers, manufactures, and markets a range of vaccines and veterinary pharmaceutical products. The company’s medicine KEYTRUDA may treat certain cancers by working with the immune system.

4. Salesforce, Inc. (NYSE:CRM)

Number of Hedge Fund Holders: 101

Salesforce, Inc. (NYSE:CRM) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. DA Davidson cut the price target on Salesforce, Inc. (NYSE:CRM) to $175 from $200 on May 28, maintaining a Neutral rating on the shares. The firm told investors in a research note that the company’s fiscal Q1 earnings represent a strong start to the year. However, it added that despite low investor expectations heading into the quarter, the results and the updated guide did not manage to provide the ammunition for bulls to get more constructive on the name and endorse the top-line acceleration story for the second half of FY27.

Salesforce, Inc. (NYSE:CRM) also received a rating update from BMO Capital the same day, with the firm cutting the price target on the stock to $215 from $225 while maintaining an Outperform rating on the shares following the company’s fiscal Q1 results. The firm told investors in a research note that the results and guidance are not likely to be sufficient to convince either bears or bulls to switch sides, and that offer limited changes to FY27 top-line growth expectations.

Salesforce, Inc. (NYSE:CRM) designs and develops cloud-based enterprise software for customer relationship management. Its solutions encompass customer service and support, sales force automation, digital commerce, marketing automation, collaboration, community management, industry-specific solutions, and Salesforce platforms. It also offers training, guidance, support, and advisory services.

3. Chevron Corporation (NYSE:CVX)

Number of Hedge Fund Holders: 103

Chevron Corporation (NYSE:CVX) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. On May 26, Barclays lifted the price target on Chevron Corporation (NYSE:CVX) to $213 from $192 and maintained an Equal Weight rating on the shares. It told investors in a research note that factors such as depleting inventories, a “muted” U.S. production response to the Middle East war, and a shrinking OPEC spare capacity are reinforcing a tighter oil macro backdrop that is not fully reflected in equities. These circumstances set up the “oily” exploration and production companies for a share re-rating post the conflict, according to Barclays. The firm also cut its gas price outlook on near-term oversupply while adjusting ratings and price targets in the integrated oil and exploration and production group.

Chevron Corporation (NYSE:CVX) also received a rating update from Mizuho on May 27. The firm lifted the price target on the stock to $230 from $225 and reiterated an Outperform rating on the shares, stating that it anticipates prolonged effects of the Iran crisis on global oil prices and refining cracks.

Chevron Corporation (NYSE:CVX) provides oil and gas energy solutions, including crude oil and natural gas, the manufacture of transportation fuels, petrochemicals, lubricants, and additives, and the development of technologies that boost business and the industry. Its operations are divided into the Upstream and Downstream segments.

2. Sandisk Corporation (NASDAQ:SNDK)

Number of Hedge Fund Holders: 114

Sandisk Corporation (NASDAQ:SNDK) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. Susquehanna lifted the price target on Sandisk Corporation (NASDAQ:SNDK) to $3,250 from $2,000 on May 29, maintaining a Positive rating on the shares. The firm stated that its checks suggest Q2 DRAM average selling prices are trending to be up 50%-60% quarter-over-quarter, ahead of expectations of up 50%. Meanwhile, NAND ASPs are trending unchanged at up 75-100% quarter-over-quarter. Susquehanna lifted estimates for memory manufacturers under its coverage, driven by growing confidence in the sustainability of the margin profile and the continued strength in blended ASPs.

Sandisk Corporation (NASDAQ:SNDK) also received a rating update from Mizuho on May 28, with the firm lifting the price target on the stock to $1,825 from $1,625 while maintaining an Outperform rating on the shares. The firm stated that it increased targets in the semiconductor space after analyzing the memory market and the impact of agentic AI. It further told investors in a research note that it believes DRAM demand will be strong into 2027, as NAND demand is not slowing down, and high bandwidth memory’s total addressable market is growing.

Sandisk Corporation (NASDAQ:SNDK) is involved in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. The company’s products include solid-state drives, memory cards, and USB flash drives.

1. Micron Technology, Inc. (NASDAQ:MU)

Number of Hedge Fund Holders: 154

Micron Technology, Inc. (NASDAQ:MU) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. Susquehanna lifted the price target on Micron Technology, Inc. (NASDAQ:MU) to $1,750 from $600 on May 29 and maintained a Positive rating on the shares. The firm stated that its checks suggest Q2 DRAM average selling prices are trending to be up 50%-60% quarter-over-quarter, ahead of expectations of up 50%. Meanwhile, NAND ASPs are trending unchanged at up 75-100% quarter-over-quarter. Susquehanna lifted estimates for memory manufacturers under its coverage, driven by growing confidence in the sustainability of the margin profile and the continued strength in blended ASPs.

In a separate development, Micron Technology, Inc. (NASDAQ:MU) announced on May 5 that it is now shipping the 245TB capacity Micron® 6600 ION SSD, which marks the highest capacity commercially available SSD in the world. The company stated that the drive is a notable step forward in rack-scale storage density for data centers, specifically designed to support AI, enterprise, cloud, and hyperscale workloads. These include next-generation AI data lakes and cloud-scale file and object storage.

Micron Technology, Inc. (NASDAQ:MU) provides innovative memory and storage solutions. Its operations are divided into the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU).

While we acknowledge the potential of MU to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MU and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.